• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
DNA Sequencing 2013: Market Developments, Growth Areas and Opportunities - Product Image

DNA Sequencing 2013: Market Developments, Growth Areas and Opportunities

  • Published: June 2013
  • Region: Global
  • 204 Pages
  • BioPharm Reports (VennBio Ltd.)

Summary: This market analysis was carried out to provide business information to developers, manufacturers and suppliers in the DNA sequencing field.

Its findings include:

- Marketing and sales opportunities
- End-user purchasing decisions
- Market growth and shrinkage
- Innovation and new product opportunities

This study was conducted through specialist groups of experienced DNA sequencing end-users and its findings are therefore based on 'real world' market data.

Market Analysis and Opportunities

A competitive market analysis of current practices and future developments across 25 key market areas in the DNA sequencing field.

Examples include:

- DNA Sequencing Techniques: Which DNA sequencing techniques are the market leaders and what changes do end-users predict over the next three years. Which DNA sequencing techniques are growing and which are reducing?
- DNA Sequencing Applications: Which DNA sequencing applications are the market leaders and what changes do end-users predict over the next three years. Which DNA sequencing applications are growing and which are reducing?
- Suppliers: Who are the major company suppliers READ MORE >

Executive Summary

Chapter 1 Introduction

Chapter 2 Study Participants

2.1 This Chapter
2.2 Countries
2.3 Regions
2.4 Organisation Types
2.5 Fields
2.6 DNA Sequencing Activities
2.7 Participants
2.8 Discussion

Figure 2.1 Countries of individuals who participated in DNA Sequencing 2012/13
Figure 2.2 Global regions of individuals who participated in DNA Sequencing 2012/13.
Figure 2.3 Organisation types of individuals who participated in DNA Sequencing 2012/13
Figure 2.4 Fields of individuals who participated in DNA Sequencing 2012/13
Table 2.1 Countries of individuals who participated in DNA Sequencing 2012/13
Table 2.2 Global regions of individuals who participated in DNA Sequencing 2012/13
Table 2.3 Organisation types of individuals who participated in DNA Sequencing 2012/13

Chapter 3 DNA Sequencing Techniques

3.1 This Chapter
3.2 Current Techniques
3.3 Future Techniques
3.4 Discussion

Figure 3.1 Top ten currently used DNA Sequencing techniques, indicated by individuals who participated in DNA Sequencing 2012/13
Table 3.1 Currently used DNA Sequencing techniques, indicated by individuals who participated in DNA Sequencing 2012/13
Figure 3.2 Other currently used DNA Sequencing techniques, indicated by individuals who participated in DNA Sequencing 2012/13
Table 3.2 Other currently used DNA Sequencing techniques, indicated by individuals who participated in DNA Sequencing 2012/13
Figure 3.3 Top ten DNA Sequencing techniques that end-users anticipate they will be using over the next three years (2012/13 to 2015/2016), indicated by individuals who participated in DNA Sequencing 2012/13
Table 3.3 DNA Sequencing techniques that end-users anticipate they will be using over the next three years (2012/13 to 2015/2016), indicated by individuals who participated in DNA Sequencing 2012/13
Figure 3.4 Other DNA Sequencing techniques that end-users anticipate they will be using over the next three years (2012/13 to 2015/2016), indicated by individuals who participated in DNA Sequencing 2012/13
Table 3.4 Other DNA Sequencing techniques that end-users anticipate they will be using over the next three years (2012/13 to 2015/2016), indicated by individuals who participated DNA Sequencing 2012/13

Chapter 4 DNA Sequencing Applications

4.1 This Chapter
4.2 Current Applications
4.3 Future Applications
4.4 Discussion

Figure 4.1 Top ten currently used DNA Sequencing applications, indicated by individuals who participated in DNA Sequencing 2012/13
Table 4.1 Currently used DNA Sequencing applications, indicated by individuals who participated in DNA Sequencing 2012/13
Figure 4.2 Other currently used DNA Sequencing applications, indicated by individuals who participated in DNA Sequencing 2012/13
Table 4.2 Other currently used DNA Sequencing applications, indicated by individuals who participated in DNA Sequencing 2012/13
Figure 4.3 Top ten DNA Sequencing applications that end-users anticipate they will be using over the next three years (2012/13 to 2015/2016), indicated by individuals who participated in DNA Sequencing 2012/13
Table 4.3 DNA Sequencing applications that end-users anticipate they will be using over the next three years (2012/13 to 2015/2016), indicated by individuals who participated in DNA Sequencing 2012/13
Figure 4.4 Other DNA Sequencing applications that end-users anticipate they will be using over the next three years (2012/13 to 2015/2016), indicated by individuals who participated in DNA Sequencing 2012/13
Table 4.4 Other DNA Sequencing applications that end-users anticipate they will be using over the next three years (2012/13 to 2015/2016), indicated by individuals who participated in DNA Sequencing 2012/13

Chapter 5 Companies

5.1 This Chapter
5.2 Current Companies
5.3 Future Companies
5.4 Discussion

Figure 5.1 Top ten DNA Sequencing company suppliers, currently used by individuals who participated in DNA Sequencing 2012/13
Table 5.1 DNA Sequencing company suppliers, currently used by individuals who participated in DNA Sequencing 2012/13
Figure 5.2 Other DNA Sequencing company suppliers, currently used by individuals who participated in DNA Sequencing 2012/13
Table 5.2 Other DNA Sequencing company suppliers, currently used by individuals who participated in DNA Sequencing 2012/13
Figure 5.3 Top ten DNA Sequencing company suppliers that end-users anticipate they will be using over the next three years (2012/13 to 2015/2016), indicated by individuals who participated in DNA Sequencing 2012/13
Table 5.3 DNA Sequencing company suppliers that end-users anticipate they will be using over the next three years (2012/13 to 2015/2016), indicated by individuals who participated in DNA Sequencing 2012/13
Figure 5.4 Other DNA Sequencing company suppliers that end-users anticipate they will be using over the next three years (2012/13 to 2015/2016), indicated by individuals who participated in DNA Sequencing 2012/13
Table 5.4 Other DNA Sequencing company suppliers that end-users anticipate they will be using over the next three years (2012/13 to 2015/2016), indicated by individuals who participated in DNA Sequencing 2012/13

Chapter 6 Preferred Companies and Products

6.1 This Chapter
6.2 Preferred Companies
6.3 Preferred products
6.4 Strengths
6.5 Weaknesses
6.6 Discussion

Figure 6.1 Top ten preferred suppliers in the DNA Sequencing field, indicated by individuals who participated in DNA Sequencing 2012/13
Table 6.1 Preferred suppliers in the DNA Sequencing field, indicated by individuals who participated in DNA Sequencing 2012/13
Figure 6.2 Other preferred suppliers in the DNA Sequencing field, indicated by individuals who participated in DNA Sequencing 2012/13
Table 6.2 Other preferred suppliers in the DNA Sequencing field, indicated by individuals who participated in DNA Sequencing 2012/13
Figure 6.3 Top ten preferred products in the DNA Sequencing field, indicated by individuals who participated in DNA Sequencing 2012/13
Table 6.3 Preferred products in the DNA Sequencing field, indicated by individuals who participated in DNA Sequencing 2012/13
Figure 6.4 Other preferred products in the DNA Sequencing field, indicated by individuals who participated in DNA Sequencing 2012/13
Table 6.4 Other Top preferred products in the DNA Sequencing field, indicated by individuals who participated in DNA Sequencing 2012/13
Figure 6.5 Top ten strengths of preferred products in the DNA Sequencing field, indicated by individuals who participated in DNA Sequencing 2012/13
Table 6.5 Strengths of preferred products in the DNA Sequencing field, indicated by individuals who participated in DNA Sequencing 2012/13
Figure 6.6 Other strengths of preferred products in the DNA Sequencing field, indicated by individuals who participated in DNA Sequencing 2012/13
Table 6.6 Other strengths of preferred products in the DNA Sequencing field, indicated by individuals who participated in DNA Sequencing 2012/13
Figure 6.7 Top ten weaknesses of preferred products in the DNA Sequencing field, indicated by individuals who participated in DNA Sequencing 2012/13
Table 6.7 Weaknesses of preferred products in the DNA Sequencing field, indicated by individuals who participated in DNA Sequencing 2012/13
Figure 6.8 Other weaknesses of preferred products in the DNA Sequencing field, indicated by individuals who participated in DNA Sequencing 2012/13
Table 6.8 Other weaknesses of preferred products in the DNA Sequencing field, indicated by individuals who participated in DNA Sequencing 2012/13

Chapter 7 DNA Sequencing Expenditure and Budgets

7.1 This Chapter
7.2 Current Financial budget
7.3 Future Expenditure
7.4 Future General Budget

Figure 7.1 Annual financial budgets for DNA Sequencing studies, indicated by individuals who participated in DNA Sequencing 2012/13
Table 7.1 Annual financial budgets for DNA Sequencing studies, indicated by individuals who participated in DNA Sequencing 2012/13
Figure 7.2 The breakdown of current financial budgets for DNA Sequencing studies, indicated by individuals who participated in DNA Sequencing 2012/13
Table 7.2 The breakdown of current financial budgets for DNA Sequencing studies, indicated by individuals who participated in DNA Sequencing 2012/13
Figure 7.3 The anticipated future breakdown of financial budgets (over the next three years, 2012/13 to 2015/2016) for DNA Sequencing studies, indicated by individuals who participated in DNA Sequencing 2012/13
Table 7.3 The anticipated future breakdown of financial budgets (over the next three years, 2012/13 to 2015/2016) for DNA Sequencing studies, indicated by individuals who participated in DNA Sequencing 2012/13

Chapter 8 Purpose of DNA Sequencing Use

8.1 This Chapter
8.2 Purpose
8.3 Discussion

Figure 8.1 Top ten reasons for using DNA Sequencing in the biotechnology industry, indicated by individuals who participated in DNA Sequencing 2012/13
Figure 8.2 Top ten reasons for using DNA Sequencing in clinics or hospitals, indicated by individuals who participated in DNA Sequencing 2012/13
Figure 8.3 Top ten reasons for using DNA Sequencing in the environmental industry, indicated by individuals who participated in DNA Sequencing 2012/13
Figure 8.4 Top ten reasons for using DNA Sequencing in the food and drink industry, indicated by individuals who participated in DNA Sequencing 2012/13
Figure 8.5 Top ten reasons for using DNA Sequencing in the environmental industry, indicated by individuals who participated in DNA Sequencing 2012/13
Figure 8.6 Top ten reasons for using DNA Sequencing in the Government organisations, indicated by individuals who participated in DNA Sequencing 2012/13
Figure 8.7 Top ten reasons for using DNA Sequencing in the healthcare industry, indicated by individuals who participated in DNA Sequencing 2012/13
Figure 8.8 Top ten reasons for using DNA Sequencing in the pharmaceutical industry, indicated by individuals who participated in DNA Sequencing 2012/13
Figure 8.9 Top ten reasons for using DNA Sequencing in research institutes, indicated by individuals who participated in DNA Sequencing 2012/13
Figure 8.10 Top ten reasons for using DNA Sequencing in universities, indicated by individuals who participated in DNA Sequencing 2012/13

Chapter 9 Samples

9.1 This Chapter
9.2 Samples
9.3 Discussion

Figure 9.1 Top ten sample types analysed using DNA Sequencing, indicated by individuals who participated in DNA Sequencing 2012/13
Table 9.1 Sample types analysed using DNA Sequencing, indicated by individuals who participated in DNA Sequencing 2012/13

Chapter 10 Sample Preparation

10.1 This Chapter
10.2 Sample Preparation
10.3 Discussion

Figure 10.1 Top sample preparation methods of DNA Sequencing users who participated in DNA Sequencing 2012/13
Table 10.1 Sample preparation methods of DNA Sequencing users who participated in DNA Sequencing 2012/13
Figure 10.2 Other sample preparation methods of DNA Sequencing users who participated in DNA Sequencing 2012/13
Table 10.2 Other sample preparation methods of DNA Sequencing users who participated in DNA Sequencing 2012/13

Chapter 11 Therapeutic Areas

11.1 This Chapter
11.2 Therapeutic Areas
11.3 Discussion

Figure 11.1 Top ten therapeutic areas of DNA Sequencing users who participated in DNA Sequencing 2012/13
Table 11.1 Therapeutic areas of DNA Sequencing users who participated in DNA Sequencing 2012/13
Figure 11.2 Other therapeutic areas of DNA Sequencing users who participated in DNA Sequencing 2012/13
Table 11.2 Other therapeutic areas of DNA Sequencing users who participated in DNA Sequencing 2012/13

Chapter 12 Disease Biomarkers

12.1 This Chapter
12.2 Use of DNA Sequencing
12.3 Biomarker Types
12.4 Clinical Utility
12.5 Discussion

Figure 12.1 The use of DNA Sequencing for the study of disease biomarkers, indicated by individuals who participated in DNA Sequencing 2012/13
Figure 12.2 Principal disease biomarkers studied using DNA Sequencing, indicated by individuals who participated in DNA Sequencing 2012/13
Table 12.1 Other disease biomarkers studied using DNA Sequencing, indicated by individuals who participated in DNA Sequencing 2012/13
Figure 12.3 Clinical utilities of disease biomarkers studied using DNA Sequencing, indicated by individuals who participated in DNA Sequencing 2012/13
Table 12.2 Other clinical utilities of disease biomarkers studied using DNA Sequencing, indicated by individuals who participated in DNA Sequencing 2012/13

Chapter 13 Bioinformatics Software

13.1 This Chapter
13.2 Bioinformatics Software
13.3 Discussion

Figure 13.1 Top ten bioinformatics software system used for DNA Sequencing, indicated by users who participated in DNA Sequencing 2012/13
Table 13.1 Bioinformatics software system used for DNA DNA Sequencing, indicated by users who participated in DNA Sequencing 2012/13
Figure 13.2 Other bioinformatics software system used for DNA Sequencing, indicated by users who participated in DNA Sequencing 2012/13
Table 13.2 Other bioinformatics software system used for DNA Sequencing, indicated by users who participated in DNA Sequencing 2012/13

Chapter 14 Challenging Applications

14.1 This Chapter
14.2 Most challenging Molecules
14.3 Most challenging sample types (matrices)
14.4 DNA Sequencing methods used
14.5 Underlying reasons
14.6 Discussion

Figure 14.1 The most challenging molecules studies using DNA Sequencing, indicated by users who participated in DNA Sequencing 2012/13
Table 14.1 The most challenging molecules studies using DNA Sequencing, indicated by users who participated in DNA Sequencing 2012/13
Figure 14.2 The most challenging sample types (matrices) studies using DNA Sequencing, indicated by users who participated in DNA Sequencing 2012/13
Table 14.2 The most challenging sample types (matrices) studies using DNA Sequencing, indicated by users who participated in DNA Sequencing 2012/13
Figure 14.3 Top ten DNA Sequencings methods used with the most challenging molecules studies using DNA Sequencing, indicated by users who participated in DNA Sequencing 2012/13
Table 14.3 DNA Sequencings methods used with the most challenging molecules studies using DNA Sequencing, indicated by users who participated in DNA Sequencing 2012/13
Figure 14.4 Top ten underlying reasons for the challenges encountered using DNA Sequencing analysis, indicated by users who participated in DNA Sequencing 2012/13
Table 14.4 Underlying reasons for the challenges encountered using DNA Sequencing analysis, indicated by users who participated in DNA Sequencing 2012/13

Chapter 15 Innovation

15.1 This Chapter
15.2 Required Innovation
15.3 Recent Innovation
15.4 Future Innovation
15.5 Discussion

Figure 15.1 Top ten most required areas of innovation in DNA Sequencing, indicated by individuals who participated in DNA Sequencing 2012/13
Table 15.1 Most required areas of innovation in DNA Sequencing, indicated by individuals who participated in DNA Sequencing 2012/13
Figure 15.2 Other required areas of innovation in DNA Sequencing, indicated by individuals who participated in DNA Sequencing 2012/13
Table 15.2 Other required areas of innovation in DNA Sequencing, indicated by individuals who participated in DNA Sequencing 2012/13
Figure 15.3 Top ten recent innovations (in the last three years) in DNA Sequencing, indicated by individuals who participated in DNA Sequencing 2012/13
Table 15.3 Recent innovations (in the last three years) in DNA Sequencing, indicated by individuals who participated in DNA Sequencing 2012/13
Figure 15.4 Top ten future anticipated innovations (in the next three years) in DNA Sequencing, indicated by individuals who participated in DNA Sequencing 2012/13
Table 15.4 Future anticipated innovations (in the next three years) in DNA Sequencing, indicated by individuals who participated in DNA Sequencing 2012/13

Chapter 16 Quality Control

16.1 This Chapter
16.2 Quality Control
16.3 Future Innovation
16.4 Discussion

Figure 16.1 Top ten most commonly used quality control guidelines or procedures used in DNA Sequencing analysis, indicated by individuals who participated in DNA Sequencing 2012/13
Table 16.1 Quality control guidelines or procedures used in DNA Sequencing analysis, indicated by individuals who participated in DNA Sequencing 2012/13

Chapter 17 DNA Sequencing Consumables

Chapter 18 Discussion

Chapter 19 Appendices

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos